Registered User Login
Asian Journal of Pharmaceutical Analysis
ISSN: 2231-5675(Online), 2231-5667(Print)
Home
|
About AJPA
|
Current Issue
|
Archives
|
Editorial Board
|
Instructions
|
Paper Submission
|
News & Conferences
|
Subscription
|
Corrigendum
|
Contact Us
Volume No. :
2
Issue No. :
4
Year :
2012
ISSN Print :
2231-5667
ISSN Online :
2231-5675
Registration
Allready Registrered
Click to Login
UV- Spectrophotometric Method Development and Validation for Estimation of Tizanidine and Aceclofenac in Tablet Formulation
Jumle R. S.*
,
Mundhey A.S.
,
Wate S.P.
,
Dangare S.S.
,
Ramteke U.D.
rjumle2010@gmail.com
Address:
Jumle R. S.*, Mundhey A.S., Wate S.P., Dangare S.S., Ramteke U.D.
Department of Pharmaceutical Chemistry, Sharad Pawar College of Pharmacy Nagpur, India
*Corresponding Author
DOI No:
ABSTRACT:
The present study deals with UV spectrophotometric method development and validation for estimation of Tizanidine and Aceclofenac tablet dosage form by Viedort’s method and first order UV derivative spectrophotometry. The Vierodt's method involves measurement of absorbance at ?max of Tizaridine and Aceclofenac at 282 nm respectively. The linearity of Tizanidine and Aceclofenac was found to be in the range of 1-10 µg/ml respectively. The % recovery of Tizanidine and Aceclofenac was found out to be 99.2% and 99.69%s respectively. First order CV derivative spectrophotonmetry (D1 method). the zero crossing method was chosen as Tizanidine could he easily analyzed without any interference from Aceclofenac and vice-versa. Tizanidine was determined by measurement of its D1 amplitude at the zero crossing point of Aceclofenac at (270nm), While Aceclofenac was determined by measurement of its D1 amplitude at zero crossing point of Tizanidine at (318 nm) The proposed method was validated as per ICH guidelines.
KEYWORDS:
UV- Spectrophotometric Method Development and Validation for Estimation of Tizanidine and Aceclofenac in Tablet Formulation
Cite:
UV- Spectrophotometric Method Development and Validation for Estimation of Tizanidine and ceclofenac in Tablet Formulation. Asian J. Pharm. Ana. 2(4): Oct. - Dec. 2012; Page 101-103.
[View HTML]
[View PDF]
Visitor's No. :
168540